Human metabolic individuality in biomedical and pharmaceutical research
Top Cited Papers
- 31 August 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 477 (7362), 54-60
- https://doi.org/10.1038/nature10354
Abstract
Genome-wide association studies (GWAS) have identified many risk loci for complex diseases, but effect sizes are typically small and information on the underlying biological processes is often lacking. Associations with metabolic traits as functional intermediates can overcome these problems and potentially inform individualized therapy. Here we report a comprehensive analysis of genotype-dependent metabolic phenotypes using a GWAS with non-targeted metabolomics. We identified 37 genetic loci associated with blood metabolite concentrations, of which 25 show effect sizes that are unusually high for GWAS and account for 10–60% differences in metabolite levels per allele copy. Our associations provide new functional insights for many disease-related associations that have been reported in previous studies, including those for cardiovascular and kidney disorders, type 2 diabetes, cancer, gout, venous thromboembolism and Crohn’s disease. The study advances our knowledge of the genetic basis of metabolic individuality in humans and generates many new hypotheses for biomedical and pharmaceutical research.Keywords
This publication has 51 references indexed in Scilit:
- Large-scale association analysis identifies 13 new susceptibility loci for coronary artery diseaseNature Genetics, 2011
- Biological, clinical and population relevance of 95 loci for blood lipidsNature, 2010
- New loci associated with kidney function and chronic kidney diseaseNature Genetics, 2010
- New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes riskNature Genetics, 2010
- A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortiumNature Genetics, 2009
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progressionNature, 2009
- Loci influencing lipid levels and coronary heart disease risk in 16 European population cohortsNature Genetics, 2008
- Population-Based Genome-wide Association Studies Reveal Six Loci Influencing Plasma Levels of Liver EnzymesAmerican Journal of Human Genetics, 2008
- Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association studyThe Lancet, 2008
- Effect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin PharmacokineticsClinical Pharmacology & Therapeutics, 2007